Login Register Cart 0
Generic placeholder image

Current Organic Synthesis

Editor-in-Chief

ISSN (Print): 1570-1794
ISSN (Online): 1875-6271

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
General Research Article

Heteroaromatization of Coumarin Part I: Design, Synthesis, Reactions, Antitumor Activities of Novel Pyridine and Naphthyridine Derivatives

Author(s): Rita Mohammed Ahmed Borik and Ashraf Hassan Fekry Abd El-Wahab*

Volume 21, Issue 4, 2024

Published on: 01 January, 2024

Page: [571 - 581] Pages: 11

DOI: 10.2174/0115701794265924230920061222

Price: $65

Abstract

Introduction: A novel series of chromen-3-yl-pyridine moieties were synthesized. IR, NMR, and MS spectroscopy were used to confirm the structure of these novel compounds and study antitumor activity of these compounds. The structure-activity relationship investigation demonstrated that 2,4-diamino- 5-(3-methoxyphenyl)-7-(2-oxo-2H-chromen-3-yl)-1,8-naphthyridine-3-carbonitrile (16), naphthyridine- 3-carbonitrile derivatives 17, 18 and pyrido[2,3-d]pyrimidine derivative 12 were found to be more effective, while compounds 5a,b, 9c, 11, 13 and 14 showed moderate activity for antitumor activities.

Objectives: The objective was to design a series of new chromen-3-yl-pyridine and pyrido[2,3-d]pyrimidine derivatives and study the antitumor of these compounds.

Materials and Methods: The condensation reaction of 3-acetyl-2H-chromen-2-one with 3-methoxy benzaldehyde and malononitrile or ethyl cyanoacetate in the presence of ammonium acetate and acetic acid under reflux to give the corresponding chromen-3-yl pyridine-3-carbonitrile derivatives.

Results: In this study, the antitumor activity of the synthesized compounds chromen-3-yl-pyridine derivatives has been determined for the broad spectrum of cytotoxic activity toward the investigated three cell lines and 5-Fluorouracil, as reference drugs.

Conclusion: A series of new chromen-3-yl-pyridine and pyrido[2,3-d]pyrimidine derivatives were synthesized in this work. All compounds were evaluated for cytotoxic activity.

« Previous
Graphical Abstract

[1]
Pavurala, S.; Vedula, R.R. An efficient, multicomponent synthesis of pyrazolyl-triazolothiadiazinyl chromen-2-ones. J. Heterocycl. Chem., 2015, 52(1), 306-309.
[http://dx.doi.org/10.1002/jhet.2027]
[2]
Bhattacharyya, S.S.; Paul, S.; Mandal, S.K.; Banerjee, A.; Boujedaini, N.; Khuda-Bukhsh, A.R.; Belon, P.; Khuda-Bukhsh, A.R. A synthetic coumarin (4-Methyl-7 hydroxy coumarin) has anti-cancer potentials against DMBA-induced skin cancer in mice. Eur. J. Pharmacol., 2009, 614(1-3), 128-136.
[http://dx.doi.org/10.1016/j.ejphar.2009.04.015] [PMID: 19393233]
[3]
Gupta, J.K.; Sharma, P.K.; Dudhe, R.; Chaudhary, A.; Verma, P.K. Synthesis, analgesic and ulcerogenic activity of novel pyrimidine derivative of coumarin moiety. Anal. Univ. Bucuresti-Chim., 2010, 19, 9-21.
[4]
Abdelhafez, O.M.; Amin, K.M.; Batran, R.Z.; Maher, T.J.; Nada, S.A.; Sethumadhavan, S. Synthesis, anticoagulant and PIVKA-II induced by new 4-hydroxycoumarin derivatives. Bioorg. Med. Chem., 2010, 18(10), 3371-3378.
[http://dx.doi.org/10.1016/j.bmc.2010.04.009] [PMID: 20435480]
[5]
Suzuki, A.Z.; Watanabe, T.; Kawamoto, M.; Nishiyama, K.; Yamashita, H.; Ishii, M.; Iwamura, M.; Furuta, T. Coumarin-4-ylmethoxycarbonyls as phototriggers for alcohols and phenols. Org. Lett., 2003, 5(25), 4867-4870.
[http://dx.doi.org/10.1021/ol0359362] [PMID: 14653694]
[6]
Ojala, T.; Remes, S.; Haansuu, P.; Vuorela, H.; Hiltunen, R.; Haahtela, K.; Vuorela, P. Antimicrobial activity of some coumarin containing herbal plants growing in Finland. J. Ethnopharmacol., 2000, 73(1-2), 299-305.
[http://dx.doi.org/10.1016/S0378-8741(00)00279-8] [PMID: 11025169]
[7]
Souza, S.M.; Monache, F.D.; Smânia, A., Jr Antibacterial activity of coumarins. Z. Naturforsch. C J. Biosci., 2005, 60(9-10), 693-700.
[http://dx.doi.org/10.1515/znc-2005-9-1006] [PMID: 16320610]
[8]
Škanj, B.; Molnar, M.; Cacic, M.; Gille, M. Antioxidant properties and growth-inhibitory activity of coumarin Schiff bases against common foodborne fungi. Food Chem., 2013, 13, 8146-8149.
[9]
Pierson, J.T.; Dumètre, A.; Hutter, S.; Delmas, F.; Laget, M.; Finet, J.P.; Azas, N.; Combes, S. Synthesis and antiprotozoal activity of 4-arylcoumarins. Eur. J. Med. Chem., 2010, 45(3), 864-869.
[http://dx.doi.org/10.1016/j.ejmech.2009.10.022] [PMID: 19914747]
[10]
Selvam, P.; Ramlakshmi, N.; Uma, G.; Kumar, S.A.; Umamasheswari, A. synthesis, characterisation and biological evaluation of novel coumarin derivatives. Rasayan J. Chem., 2010, 3, 275-280.
[11]
Kostova, I.; Bhatia, S.; Grigorov, P.; Balkansky, S.; Parmar, V.S.; Prasad, A.K.; Saso, L. Coumarins as antioxidants. Curr. Med. Chem., 2011, 18(25), 3929-3951.
[http://dx.doi.org/10.2174/092986711803414395] [PMID: 21824098]
[12]
Gonsior, E.; Schultze-Werninghaus, G.; Wüthrich, B. Protective antiallergic effects of a new coumarin compound (BM 15.100) in experimental asthma. Int. J. Clin. Pharmacol. Biopharm., 1979, 17(7), 283-289.
[PMID: 489192]
[13]
Thumber, B.L.; Vasoya, V.G.; Desai, T.R.; Naliapara, Y.T.; Shah, K.V.; Tirgar, P.R. an activity of methylated coumarin derivatives. Pharmacol. Newslett, 2011, 2, 1010-1017.
[14]
Spino, C.; Dodier, M.; Sotheeswaran, S. Anti-HIV coumarins from calophyllum seed oil. Bioorg. Med. Chem. Lett., 1998, 8(24), 3475-3478.
[http://dx.doi.org/10.1016/S0960-894X(98)00628-3] [PMID: 9934455]
[15]
Sunthitikawinsakul, A.; Kongkathip, N.; Kongkathip, B.; Phonnakhu, S.; Daly, J.W.; Spande, T.F.; Nimit, Y.; Rochanaruangrai, S. Coumarins and carbazoles from Clausena excavata exhibited antimycobacterial and antifungal activities. Planta Med., 2003, 69(2), 155-157.
[http://dx.doi.org/10.1055/s-2003-37716] [PMID: 12624822]
[16]
Weigt, S.; Huebler, N.; Strecker, R.; Braunbeck, T.; Broschard, T.H. Developmental effects of coumarin and the anticoagulant coumarin derivative warfarin on zebrafish (Danio rerio) embryos. Reprod. Toxicol., 2012, 33(2), 133-141.
[http://dx.doi.org/10.1016/j.reprotox.2011.07.001] [PMID: 21798343]
[17]
Musa, M.A.; Cooperwood, J.S.; Khan, M.O.F.; Rahman, T. In-vitro antiproliferative activity of benzopyranone derivatives in comparison with standard chemotherapeutic drugs. Arch. Pharm., 2011, 344(2), 102-110.
[http://dx.doi.org/10.1002/ardp.201000207] [PMID: 21290426]
[18]
Musa, M.A.; Badisa, V.L.D.; Latinwo, L.M.; Waryoba, C.; Ugochukwu, N. In vitro cytotoxicity of benzopyranone derivatives with basic side chain against human lung cell lines. Anticancer Res., 2010, 30(11), 4613-4617.
[PMID: 21115914]
[19]
Musa, M.A.; Khan, M.O.F.; Cooperwood, J.S. Synthesis and antiproliferative activity of coumarin-estrogen conjugates against breast cancer cell lines. Lett. Drug Des. Discov., 2009, 6(2), 133-138.
[http://dx.doi.org/10.2174/157018009787582624] [PMID: 20556210]
[20]
Williamson, R.C.; Lyndon, P.J.; Tudway, A.J. Effects of anticoagulation and ileal resection on the development and spread of experimental intestinal carcinomas. Br. J. Cancer, 1980, 42(1), 85-94.
[http://dx.doi.org/10.1038/bjc.1980.206] [PMID: 7426332]
[21]
Ryan, J.J.; Ketcham, A.S.; Wexler, H. Warfarin therapy as an adjunct to the surgical treatment of malignant tumors in mice. Cancer Res., 1969, 29(12), 2191-2194.
[PMID: 5387259]
[22]
Yang, E.B.; Zhao, Y.N.; Zhang, K.; Mack, P. Daphnetin, one of coumarin derivatives, is a protein kinase inhibitor. Biochem. Biophys. Res. Commun., 1999, 260(3), 682-685.
[http://dx.doi.org/10.1006/bbrc.1999.0958] [PMID: 10403826]
[23]
Han, S.; Zhou, V.; Pan, S.; Liu, Y.; Hornsby, M.; McMullan, D.; Klock, H.E.; Haugen, J.; Lesley, S.A.; Gray, N.; Caldwell, J.; Gu, X. Identification of coumarin derivatives as a novel class of allosteric MEK1 inhibitors. Bioorg. Med. Chem. Lett., 2005, 15(24), 5467-5473.
[http://dx.doi.org/10.1016/j.bmcl.2005.08.097] [PMID: 16199156]
[24]
Lee, S.; Sivakumar, K.; Shin, W.S.; Xie, F.; Wang, Q. Synthesis and anti-angiogenesis activity of coumarin derivatives. Bioorg. Med. Chem. Lett., 2006, 16(17), 4596-4599.
[http://dx.doi.org/10.1016/j.bmcl.2006.06.007] [PMID: 16793260]
[25]
Mirzaei, S.; Ghodsi, R.; Hadizadeh, F.; Sahebkar, A. 3D-QSAR-based pharmacophore modeling, virtual screening, and molecular docking studies for identification of tubulin inhibitors with potential anticancer activity. BioMed Res. Int., 2021, 20216480804
[http://dx.doi.org/10.1155/2021/6480804]
[26]
Hagras, M.; El Deeb, M.A.; Elzahabi, H.S.A.; Elkaeed, E.B.; Mehany, A.B.M.; Eissa, I.H. Discovery of new quinolines as potent colchicine binding site inhibitors: Design, synthesis, docking studies, and anti-proliferative evaluation. J. Enzyme Inhib. Med. Chem., 2021, 36(1), 640-658.
[http://dx.doi.org/10.1080/14756366.2021.1883598] [PMID: 33588683]
[27]
Eid, F.A.; Abd El-Wahab, A.H.F.; Ali, G.A.; Khafagy, M.M. Synthesis and antimicrobial evaluation of naphtho[2,1-b]pyrano[2,3-d]pyrimidine and pyrano[3,2-e][1,2,4]triazolo[1,5-c]pyrimidine derivatives. Acta Pharm., 2004, 54(1), 13-26.
[PMID: 15050041]
[28]
Abd El-Wahab, A.H.F. Synthesis of some new pyrano[2,3-d][1,2,4]triazolo[1,5-c]pyrimidine and pyrimido[1,6-b]triazine derivatives. Acta Pharm., 2003, 58, 701-720.
[29]
El-Agrody, A.M.; Abd El-Latif, M.S.; El-Hady, N.A.; Fakery, A.H.; Bedair, A.H. Heteroaromatization with 4-Hyroxycoumarin. Part II: Synthesis of some new pyrano[2,3-d] [1,2,4]triazolo[1,5-c]pyrimidine and pyrimido[1,6-b]triazine derivatives. Molecules, 2001, 6, 519-527.
[http://dx.doi.org/10.3390/60600519]
[30]
Bedair, A.H.; El-Haddy, N.A.; Abd El-Latif, M.S.; Fakery, A.H.; El-Agrody, A.M. 4-Hyroxycoumarin in heterocyclic synthesis. Part III: Synthesis of some new pyrano[2,3-d] pyrimidine, 2-substituted[1,2,4]triazolo[1,5-c]pyrimidine and pyrimido[1,6-b]triazine derivatives. Farmaco, 2000, 55, 708-714.
[http://dx.doi.org/10.1016/S0014-827X(00)00097-5] [PMID: 11204946]
[31]
El-Agrody, A.M.; El-Hakim, M.H.; Abd El-Latif, M.S.; Fakery, A.H.; El-Sayed, E.M.; El-Ghareab, K.A. Synthesis pyrano[2,3-d]pyrimidine and pyrano[3,2-e][1,2,4]triazolo[2,3-c] pyrimidine derivatives with promising antibacterial activities. Acta Pharm., 2000, 50, 111-120.
[32]
Khafagy, M.M.; Abd El-Wahab, A.H.F.; Eid, F.A.; El-Agrody, A. M Synthesis of halogen derivatives of benzo[h]chromene and benzo[a]anthracene with promising antimicrobial activities. Farmaco, 2002, 57(9), 715-722.
[http://dx.doi.org/10.1016/S0014-827X(02)01263-6]
[33]
Abd El-Wahab, A.H.F. Synthesis, reactions and evaluation of the antimicrobial activity of some 4-(p-halophenyl)-4h-naphthopyran, pyranopyrimidine and pyranotriazolopyrimidine derivatives. Pharmaceuticals, 2012, 5(7), 745-757.
[http://dx.doi.org/10.3390/ph5070745] [PMID: 24281710]
[34]
Bedair, A.H.; Emam, H.A.; El-Hady, N.A.; Ahmed, K.A.R.; El-Agrody, A.M. Synthesis and antimicrobial activities of novel naphtho[2,1-b]pyran, pyrano[2,3-d]pyrimidine and pyrano[3,2-e][1,2,4]triazolo[2,3-c]-pyrimidine derivatives. Farmaco, 2001, 56(12), 965-973.
[http://dx.doi.org/10.1016/S0014-827X(01)01168-5] [PMID: 11829118]
[35]
Radini, I.A.; Abd El-Wahab, A.H.F. Heteroaromatization with 4-phenyldiazenyl-1-naphthol. Part I: Synthesis of some new naphthopyrans and naphthopyranopyrimidines. Eur. J. Chem., 2016, 7(2), 230-237.
[http://dx.doi.org/10.5155/eurjchem.7.2.230-237.1432]
[36]
Ashraf, H.F.A.; Mosa, H.M.K.; Ali, H.H.A.; Mohammad, Y.M.A. Synthesis, antimicrobial, and antitumor activity of some new chromene compounds. Indian J. Heterocycl. Chem., 2020, 30, 369-379.
[37]
Abdelwahab, A.H.F.; Fekry, S.A.H. Anti-cancerous properties of the synthesized substituted chromene compounds and their pharmacological activities. Lett. Drug Des. Discov., 2023, 20(8), 1098-1106.
[http://dx.doi.org/10.2174/1570180819666220811102040]
[38]
El Azab, I.H.; Gobouri, A.A.; Altalhi, T.A. 4-chlorothiazole-5-carbaldehydes as potent precursors for synthesis of some new pendant N -heterocyces endowed with anti-tumor activity. J. Heterocycl. Chem., 2019, 56(1), 281-295.
[http://dx.doi.org/10.1002/jhet.3406]
[39]
Jian, F.Z.; Yua, Z.S.; Jin, S.L.; Gui, X.G.; Shujiang, T. Facile one pot, multicomponent synthesis of pyridines under microwave irradiation; synth. Comm, 2009, 39, 1443-1450.
[40]
Kuete, V.; Krusche, B.; Youns, M.; Voukeng, I.; Fankam, A.G.; Tankeo, S.; Lacmata, S.; Efferth, T. Cytotoxicity of some Cameroonian spices and selected medicinal plant extracts. J. Ethnopharmacol., 2011, 134(3), 803-812.
[http://dx.doi.org/10.1016/j.jep.2011.01.035] [PMID: 21291988]
[41]
Youns, M.; Fu, Y.J.; Zu, Y.G.; Kramer, A.; Konkimalla, V.B.; Radlwimmer, B.; Sültmann, H.; Efferth, T. Sensitivity and resistance towards isoliquiritigenin, doxorubicin and methotrexate in T cell acute lymphoblastic leukaemia cell lines by pharmacogenomics. Naunyn Schmiedebergs Arch. Pharmacol., 2010, 382(3), 221-234.
[http://dx.doi.org/10.1007/s00210-010-0541-6] [PMID: 20668838]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy